SlideShare ist ein Scribd-Unternehmen logo
1 von 19
Submitted to: Dr. Nayyar Parvez sir
Submitted by: Pratiksha Srivastava
M.Pharm 1st year
Galgotias university
 Pharmacokinetic modeling is a
mathematical modeling technique for
predicting the absorption, distribution,
metabolism and excretion (ADME) of
synthetic or natural chemical substances in
humans and other animal species.
• Drug movement within the body is the
complex process to describe and for analysis.
• So two major approaches in the quantitative
study of various kinetic processes of drug
disposition in the body are:
1. Model approach, and
2. Model-independent approach (non-
compartmental analysis)
Methods for analysis
of pharmacokinetic
data
Model approach
Compartment
model
1. Mammillary
model
2. Catenary
model
Physiological
model
1. perfusion-
limited model
2. diffusion-
limited model
Distributed
parameter
model
Model
independent
approach
Non-
compartm
ent
analysis
 In this approach, models are used to describe
changes in drug concentration in the body with
time.
PHARMACOKINETIC MODEL:
Pharmacokinetic model provides mathematical
expression for the time course of drugs
throughout the body and compute meaningful
pharmacokinetic parameters.
Compartment
models
• Empirical
models
Physiological
models
• Realistic models
Distributed
parameter
models
• Realistic models
 Compartment analysis is the traditional and
most commonly used approach to
pharmacokinetic characterization of a drugs.
 These models simply interpolate the
experimental data and allow an empirical
formula to estimate the drugs concentration
with time
 Since compartments are hypothetical in
nature ,compartments models are based n
certain assumptions.
1. The body is represented as a series of
compartments arranged either in series or
parallel to each other,which communicate
reversibly with each other.
2. Each compartment is not a real physiological or
anatomical region but fictitious or virtual one
and considered as a tissue or group of tissue
that have similar drug distribution
characteristics
3. Within each compartments the drugs is
considered to be rapidly and uniformly
distributed
4. The rate of drug movement between
compartments described by first order kinetics
 Depending upon whether the compartment
are arranged parallel or in series
,compartments models are divided into two
categories –
 Mammillary model
 Catenary model
 It consists of one or more peripheral
compartments connected to the central
compartment in a manner similar to
connection of satellites to a planet
 They are joined parallel to the central
compartment
 The central compartment comprises of
plasma and highly perfused tissues such as
lungs, liver, kidney etc. which rapidly
equilibrate with drugs.
Central
compartment
 The compartments are joined to one another
in a series like compartments of a train.
 It is rarely used because it is not observed
that anatomically or physiologically various
organs are directly linked to the blood
compartment.
 They are drawn on the basis of known
anatomical and physiological data
 So it present more realistic picture of
drug disposition in various organs and
tissues.
 Tissues with similar perfusion properties
are grouped into a single compartment
 e.g. lungs, liver, brain and kidney are
grouped as rapidly equilibrating tissues
 While muscles and adipose as slowly
equilibrating tissues.
 It is analogous to physiological model but
has been designed to take into account
Variations in blood flow to an organ
Variations in drug diffusion in an organ
 The distributed parameter model differ from
physiological model in that the mathematical
equation are more complex and collection of
drug concentration data is more difficult.
 k/as model independent methods
 Because it does not require the assumption
of specific compartment model.
 This method is based on the assumption that
the drugs or metabolites follow linear
kinetics,
 So this technique can be applied to any
compartment model.
 Based on statistical moments theory
 It involves collection of experimental data
following a single dose of drug
 If one consider the time course of drug
concentration in plasma as a statistical
distribution curve, then
MRT= AUMC/AUC
 Where
MRT= mean residence time
AUMC= area under the first moment
curve
AUC= Area under the zero moment curve
MRT= is defined as the average amount of time
spent by the drug in the body before being
eliminated.
AUMC and AUC can be calculated from the use
of trapezoidal rule.
 Characterizing the behavior of drugs in
patients.
 Correlating plasma drug concentration with
pharmacological response.
 Evaluating the bioequivalence
bioinequivalence between different
formulations of the same drugs.
 Determining the influence of altered
physiologydisease state on drugs ADME
 Explaining drugs interaction.

Weitere ähnliche Inhalte

Was ist angesagt?

ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)DR. METI.BHARATH KUMAR
 
Measurement of bioavailability
Measurement of bioavailabilityMeasurement of bioavailability
Measurement of bioavailabilityshikha singh
 
pH partition theory of drug absorption
pH partition theory of drug absorptionpH partition theory of drug absorption
pH partition theory of drug absorptionAravinda Palyam
 
Bioavailability and bioequivalence
Bioavailability and bioequivalenceBioavailability and bioequivalence
Bioavailability and bioequivalenceNaresh Gorantla
 
IN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATIONIN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATIONN Anusha
 
METHOD OF RESIDUALS
METHOD OF RESIDUALSMETHOD OF RESIDUALS
METHOD OF RESIDUALSDivya Pushp
 
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)DR. METI.BHARATH KUMAR
 
Bioequivalence 112070804009
Bioequivalence  112070804009Bioequivalence  112070804009
Bioequivalence 112070804009Patel Parth
 
Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1Sulekha Rohilla
 
Physiological pharmacokinetic models
Physiological pharmacokinetic modelsPhysiological pharmacokinetic models
Physiological pharmacokinetic modelsSanjay Yadav
 
Bioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesBioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesDr. Kunal Chitnis
 
Methods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugsMethods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugsDebasish Ghadei
 
Biopharmaceutics classification system
Biopharmaceutics classification systemBiopharmaceutics classification system
Biopharmaceutics classification systemAshwani Kumar Singh
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing BioavailabilityDibrugarh University
 
Two compartment model
Two compartment modelTwo compartment model
Two compartment modelRooma Khalid
 
Pharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimensPharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimensAreej Abu Hanieh
 
Basic pharmacokinetics and compartment modelling
Basic pharmacokinetics  and compartment modellingBasic pharmacokinetics  and compartment modelling
Basic pharmacokinetics and compartment modellingPriyankaDabirBharadk
 
Bioequivalence studies
Bioequivalence studiesBioequivalence studies
Bioequivalence studiesSujit Patel
 

Was ist angesagt? (20)

ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
 
Measurement of bioavailability
Measurement of bioavailabilityMeasurement of bioavailability
Measurement of bioavailability
 
pH partition theory of drug absorption
pH partition theory of drug absorptionpH partition theory of drug absorption
pH partition theory of drug absorption
 
Bioavailability and bioequivalence
Bioavailability and bioequivalenceBioavailability and bioequivalence
Bioavailability and bioequivalence
 
IN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATIONIN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATION
 
METHOD OF RESIDUALS
METHOD OF RESIDUALSMETHOD OF RESIDUALS
METHOD OF RESIDUALS
 
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
 
Bioequivalence 112070804009
Bioequivalence  112070804009Bioequivalence  112070804009
Bioequivalence 112070804009
 
Multicompartment Models
Multicompartment ModelsMulticompartment Models
Multicompartment Models
 
Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1
 
Physiological pharmacokinetic models
Physiological pharmacokinetic modelsPhysiological pharmacokinetic models
Physiological pharmacokinetic models
 
Bioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesBioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence Studies
 
Methods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugsMethods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugs
 
Biopharmaceutics classification system
Biopharmaceutics classification systemBiopharmaceutics classification system
Biopharmaceutics classification system
 
Kinetics of multiple dosing
Kinetics of multiple dosingKinetics of multiple dosing
Kinetics of multiple dosing
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing Bioavailability
 
Two compartment model
Two compartment modelTwo compartment model
Two compartment model
 
Pharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimensPharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimens
 
Basic pharmacokinetics and compartment modelling
Basic pharmacokinetics  and compartment modellingBasic pharmacokinetics  and compartment modelling
Basic pharmacokinetics and compartment modelling
 
Bioequivalence studies
Bioequivalence studiesBioequivalence studies
Bioequivalence studies
 

Ähnlich wie Pharmacokinetic models

Pharmacokinetic models(biopharmaceutics)
Pharmacokinetic models(biopharmaceutics)Pharmacokinetic models(biopharmaceutics)
Pharmacokinetic models(biopharmaceutics)MdIrfanUddin2
 
Basic Pharmacokinetics & Compartments Modelling.pdf
Basic Pharmacokinetics & Compartments Modelling.pdfBasic Pharmacokinetics & Compartments Modelling.pdf
Basic Pharmacokinetics & Compartments Modelling.pdfAshwin Saxena
 
basicpharmacokineticsandcompatmentmodelling-171223090651.ppt
basicpharmacokineticsandcompatmentmodelling-171223090651.pptbasicpharmacokineticsandcompatmentmodelling-171223090651.ppt
basicpharmacokineticsandcompatmentmodelling-171223090651.pptTohfatulJinan1
 
Basic concepts of pharmacokinetics
Basic concepts of pharmacokineticsBasic concepts of pharmacokinetics
Basic concepts of pharmacokineticsAnand Addagalla
 
Basic concepts of pharmacokinetics
Basic concepts of pharmacokineticsBasic concepts of pharmacokinetics
Basic concepts of pharmacokineticsAnand Addagalla
 
Compartment modeling ppt
Compartment modeling pptCompartment modeling ppt
Compartment modeling pptbinu anand
 
pharmacokinetics
 pharmacokinetics pharmacokinetics
pharmacokineticsKhadga Raj
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
Pharma co kinetics compartmental modeling
Pharma co kinetics compartmental modeling Pharma co kinetics compartmental modeling
Pharma co kinetics compartmental modeling Manjit Kaur
 
Physiologic, pharmacokinetic models, statistic moment,.pptx
Physiologic, pharmacokinetic models, statistic moment,.pptxPhysiologic, pharmacokinetic models, statistic moment,.pptx
Physiologic, pharmacokinetic models, statistic moment,.pptxMdHimelAhmedRidoy1
 
Basic Pharmacokinetics & Compartment Modelling.pptx
Basic Pharmacokinetics & Compartment Modelling.pptxBasic Pharmacokinetics & Compartment Modelling.pptx
Basic Pharmacokinetics & Compartment Modelling.pptxAshwin Saxena
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxARSHIKHANAM4
 

Ähnlich wie Pharmacokinetic models (20)

Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Pharmacokinetic models(biopharmaceutics)
Pharmacokinetic models(biopharmaceutics)Pharmacokinetic models(biopharmaceutics)
Pharmacokinetic models(biopharmaceutics)
 
Basic Pharmacokinetics & Compartments Modelling.pdf
Basic Pharmacokinetics & Compartments Modelling.pdfBasic Pharmacokinetics & Compartments Modelling.pdf
Basic Pharmacokinetics & Compartments Modelling.pdf
 
basicpharmacokineticsandcompatmentmodelling-171223090651.ppt
basicpharmacokineticsandcompatmentmodelling-171223090651.pptbasicpharmacokineticsandcompatmentmodelling-171223090651.ppt
basicpharmacokineticsandcompatmentmodelling-171223090651.ppt
 
PHARMACOKINETIC MODELS
PHARMACOKINETIC MODELSPHARMACOKINETIC MODELS
PHARMACOKINETIC MODELS
 
Basic concepts of pharmacokinetics
Basic concepts of pharmacokineticsBasic concepts of pharmacokinetics
Basic concepts of pharmacokinetics
 
Basic concepts of pharmacokinetics
Basic concepts of pharmacokineticsBasic concepts of pharmacokinetics
Basic concepts of pharmacokinetics
 
Compartment modeling ppt
Compartment modeling pptCompartment modeling ppt
Compartment modeling ppt
 
1.pharmacokinetics
1.pharmacokinetics1.pharmacokinetics
1.pharmacokinetics
 
Concept of non linear and linear pharmacokinetic model
Concept of non linear and linear pharmacokinetic modelConcept of non linear and linear pharmacokinetic model
Concept of non linear and linear pharmacokinetic model
 
pharmacokinetics
 pharmacokinetics pharmacokinetics
pharmacokinetics
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
Lecture 8.pdf
Lecture 8.pdfLecture 8.pdf
Lecture 8.pdf
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Pharma co kinetics compartmental modeling
Pharma co kinetics compartmental modeling Pharma co kinetics compartmental modeling
Pharma co kinetics compartmental modeling
 
Physiologic, pharmacokinetic models, statistic moment,.pptx
Physiologic, pharmacokinetic models, statistic moment,.pptxPhysiologic, pharmacokinetic models, statistic moment,.pptx
Physiologic, pharmacokinetic models, statistic moment,.pptx
 
Basics of Pharmacokinetics
Basics of PharmacokineticsBasics of Pharmacokinetics
Basics of Pharmacokinetics
 
Basic Pharmacokinetics & Compartment Modelling.pptx
Basic Pharmacokinetics & Compartment Modelling.pptxBasic Pharmacokinetics & Compartment Modelling.pptx
Basic Pharmacokinetics & Compartment Modelling.pptx
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptx
 

Kürzlich hochgeladen

Chemistry 4th semester series (krishna).pdf
Chemistry 4th semester series (krishna).pdfChemistry 4th semester series (krishna).pdf
Chemistry 4th semester series (krishna).pdfSumit Kumar yadav
 
Animal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxAnimal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxUmerFayaz5
 
Green chemistry and Sustainable development.pptx
Green chemistry  and Sustainable development.pptxGreen chemistry  and Sustainable development.pptx
Green chemistry and Sustainable development.pptxRajatChauhan518211
 
Chromatin Structure | EUCHROMATIN | HETEROCHROMATIN
Chromatin Structure | EUCHROMATIN | HETEROCHROMATINChromatin Structure | EUCHROMATIN | HETEROCHROMATIN
Chromatin Structure | EUCHROMATIN | HETEROCHROMATINsankalpkumarsahoo174
 
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptxanandsmhk
 
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPirithiRaju
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxgindu3009
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSarthak Sekhar Mondal
 
Zoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdfZoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdfSumit Kumar yadav
 
DIFFERENCE IN BACK CROSS AND TEST CROSS
DIFFERENCE IN  BACK CROSS AND TEST CROSSDIFFERENCE IN  BACK CROSS AND TEST CROSS
DIFFERENCE IN BACK CROSS AND TEST CROSSLeenakshiTyagi
 
Botany krishna series 2nd semester Only Mcq type questions
Botany krishna series 2nd semester Only Mcq type questionsBotany krishna series 2nd semester Only Mcq type questions
Botany krishna series 2nd semester Only Mcq type questionsSumit Kumar yadav
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...Sérgio Sacani
 
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls Agency
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls AgencyHire 💕 9907093804 Hooghly Call Girls Service Call Girls Agency
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls AgencySheetal Arora
 
Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhousejana861314
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfmuntazimhurra
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)PraveenaKalaiselvan1
 
Botany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfBotany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfSumit Kumar yadav
 
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCESTERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCEPRINCE C P
 

Kürzlich hochgeladen (20)

Chemistry 4th semester series (krishna).pdf
Chemistry 4th semester series (krishna).pdfChemistry 4th semester series (krishna).pdf
Chemistry 4th semester series (krishna).pdf
 
Animal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxAnimal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptx
 
Green chemistry and Sustainable development.pptx
Green chemistry  and Sustainable development.pptxGreen chemistry  and Sustainable development.pptx
Green chemistry and Sustainable development.pptx
 
Chromatin Structure | EUCHROMATIN | HETEROCHROMATIN
Chromatin Structure | EUCHROMATIN | HETEROCHROMATINChromatin Structure | EUCHROMATIN | HETEROCHROMATIN
Chromatin Structure | EUCHROMATIN | HETEROCHROMATIN
 
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
 
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
 
The Philosophy of Science
The Philosophy of ScienceThe Philosophy of Science
The Philosophy of Science
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptx
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
 
Zoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdfZoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdf
 
DIFFERENCE IN BACK CROSS AND TEST CROSS
DIFFERENCE IN  BACK CROSS AND TEST CROSSDIFFERENCE IN  BACK CROSS AND TEST CROSS
DIFFERENCE IN BACK CROSS AND TEST CROSS
 
Botany krishna series 2nd semester Only Mcq type questions
Botany krishna series 2nd semester Only Mcq type questionsBotany krishna series 2nd semester Only Mcq type questions
Botany krishna series 2nd semester Only Mcq type questions
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
 
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls Agency
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls AgencyHire 💕 9907093804 Hooghly Call Girls Service Call Girls Agency
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls Agency
 
Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhouse
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdf
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)
 
Botany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfBotany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdf
 
CELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdfCELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdf
 
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCESTERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
 

Pharmacokinetic models

  • 1. Submitted to: Dr. Nayyar Parvez sir Submitted by: Pratiksha Srivastava M.Pharm 1st year Galgotias university
  • 2.  Pharmacokinetic modeling is a mathematical modeling technique for predicting the absorption, distribution, metabolism and excretion (ADME) of synthetic or natural chemical substances in humans and other animal species.
  • 3. • Drug movement within the body is the complex process to describe and for analysis. • So two major approaches in the quantitative study of various kinetic processes of drug disposition in the body are: 1. Model approach, and 2. Model-independent approach (non- compartmental analysis)
  • 4. Methods for analysis of pharmacokinetic data Model approach Compartment model 1. Mammillary model 2. Catenary model Physiological model 1. perfusion- limited model 2. diffusion- limited model Distributed parameter model Model independent approach Non- compartm ent analysis
  • 5.  In this approach, models are used to describe changes in drug concentration in the body with time. PHARMACOKINETIC MODEL: Pharmacokinetic model provides mathematical expression for the time course of drugs throughout the body and compute meaningful pharmacokinetic parameters.
  • 6. Compartment models • Empirical models Physiological models • Realistic models Distributed parameter models • Realistic models
  • 7.  Compartment analysis is the traditional and most commonly used approach to pharmacokinetic characterization of a drugs.  These models simply interpolate the experimental data and allow an empirical formula to estimate the drugs concentration with time  Since compartments are hypothetical in nature ,compartments models are based n certain assumptions.
  • 8. 1. The body is represented as a series of compartments arranged either in series or parallel to each other,which communicate reversibly with each other. 2. Each compartment is not a real physiological or anatomical region but fictitious or virtual one and considered as a tissue or group of tissue that have similar drug distribution characteristics 3. Within each compartments the drugs is considered to be rapidly and uniformly distributed 4. The rate of drug movement between compartments described by first order kinetics
  • 9.  Depending upon whether the compartment are arranged parallel or in series ,compartments models are divided into two categories –  Mammillary model  Catenary model
  • 10.  It consists of one or more peripheral compartments connected to the central compartment in a manner similar to connection of satellites to a planet  They are joined parallel to the central compartment  The central compartment comprises of plasma and highly perfused tissues such as lungs, liver, kidney etc. which rapidly equilibrate with drugs.
  • 12.  The compartments are joined to one another in a series like compartments of a train.  It is rarely used because it is not observed that anatomically or physiologically various organs are directly linked to the blood compartment.
  • 13.  They are drawn on the basis of known anatomical and physiological data  So it present more realistic picture of drug disposition in various organs and tissues.  Tissues with similar perfusion properties are grouped into a single compartment  e.g. lungs, liver, brain and kidney are grouped as rapidly equilibrating tissues  While muscles and adipose as slowly equilibrating tissues.
  • 14.
  • 15.  It is analogous to physiological model but has been designed to take into account Variations in blood flow to an organ Variations in drug diffusion in an organ  The distributed parameter model differ from physiological model in that the mathematical equation are more complex and collection of drug concentration data is more difficult.
  • 16.  k/as model independent methods  Because it does not require the assumption of specific compartment model.  This method is based on the assumption that the drugs or metabolites follow linear kinetics,  So this technique can be applied to any compartment model.
  • 17.  Based on statistical moments theory  It involves collection of experimental data following a single dose of drug  If one consider the time course of drug concentration in plasma as a statistical distribution curve, then MRT= AUMC/AUC
  • 18.  Where MRT= mean residence time AUMC= area under the first moment curve AUC= Area under the zero moment curve MRT= is defined as the average amount of time spent by the drug in the body before being eliminated. AUMC and AUC can be calculated from the use of trapezoidal rule.
  • 19.  Characterizing the behavior of drugs in patients.  Correlating plasma drug concentration with pharmacological response.  Evaluating the bioequivalence bioinequivalence between different formulations of the same drugs.  Determining the influence of altered physiologydisease state on drugs ADME  Explaining drugs interaction.